Figure 3.
Schematic representation of C-dots as drug delivery systems in brain tumors in vivo. The image compares the efficacy of C-dots/drugs conjugates to free-drug approaches. The first system has a better therapeutic effect because of its ability to cross the BBB and inhibit tumor growth, thus enhancing survivability.